![]() TriAltus Bioscience TriAltus Bioscience is a company that provides life scientists with tools for production and purification of genetically-engineered proteins. | ![]() Nelson Laboratories Bozeman Nelson Laboratories Bozeman (formerly BioScience Laboratories) is a company that provides testing laboratory services. | Mispro Biotech Services Mispro Biotech Services is a company that offers the biopharmaceutical and life sciences community multi-user vivarium research space and services. | ![]() Cytiva Italy Cytiva Italy is a company that provides tools and services for the development, manufacture, and delivery of medicines. | ![]() Prothena Prothena is a global biotechnology company seeking to fundamentally alter the course of progressive diseases. | |
Founding Date | Founding Date 2017 | Founding Date 1991 | Founding Date 2003 | Founding Date 2022 | Founding Date 2012 |
Type | Type Private | Type Subsidiary | Type Private | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Birmingham, US HQ | Locations Bozeman, US HQ | Locations New York, US HQ | Locations Buccinasco, IT HQ | Locations Dublin, IE HQ South San Francisco, US |
Employees | Employees 9 | Employees 554% decrease | Employees 79 | Employees 89 | Employees 163 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) €87.3m (Y, 2024) | Revenue (est.) $9.7m (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income N/A | Net income €4.3m (Y, 2024) | Net income ($244.1m) (FY, 2025) |

Nelson Laboratories Bozeman (formerly BioScience Laboratories) is a company that provides testing laboratory services.
View companyMispro Biotech Services is a company that offers the biopharmaceutical and life sciences community multi-user vivarium research space and services.
View company
Cytiva Italy is a company that provides tools and services for the development, manufacture, and delivery of medicines.
View company
Prothena is a global biotechnology company seeking to fundamentally alter the course of progressive diseases.
View company